FRIDAY, July 26 (HealthDay News) -- Older adults with dementia
who use certain blood pressure medications may have a slower rate
of mental decline, new research suggests.
The study, reported July 25 in
BMJ Open, found that dementia patients on particular ACE
inhibitors showed a somewhat slower decline in memory and other
mental skills than patients not on the drugs.
And dementia patients who were newly started on the drugs had,
on average, a small improvement in the first six months.
The drugs linked to the benefit are known as centrally acting
ACE inhibitors, which means they cross from the blood into the
brain. They include commonly used medications such as captopril
(Capoten), fosinopril (Monopril), lisinopril (Prinivil or Zestril),
perindopril (Aceon), ramipril (Altace) and trandolapril
However, the findings do not mean that people with dementia
should be started on those ACE inhibitors, according to a
neurologist who was not involved with the research.
The study was not a clinical trial set up to test the effects of
ACE inhibitors, noted Dr. Gayatri Devi, of Lenox Hill Hospital in
New York City.
Instead, she said, it was an "observational" study, where
researchers followed more than 350 older adults with Alzheimer's or
other forms of dementia -- about one-quarter of whom happened to be
on ACE inhibitors. Those types of studies cannot prove that a drug
is the reason for a particular benefit.
"And there are past studies that have contradicted this one, and have not shown a benefit of ACE inhibitors," Devi said.
On the other hand, the findings support the "larger message"
that better cardiovascular health -- including controlling blood
pressure and cholesterol levels -- can benefit the brain as well,
Previous studies have linked better blood pressure control --
and various classes of blood pressure drugs -- to both a lower risk
of developing dementia and a slower progression of the disease.
Currently, no treatments exist to prevent or modify dementia.
"The blood pressure medication that's best for you is the one that most effectively controls your blood pressure," Devi said. "People respond differently to the different classes of blood pressure drugs."
The study included 361 dementia patients, average age 77, who
completed standard tests of memory, planning and other mental
abilities. Of those, 85 were already on a centrally acting ACE
inhibitor, and 30 more started on one during the study period.
On average, test scores declined by 1.8 points every six months
among patients who were already on ACE inhibitors. That compared
with 2.1 points for patients not on the drugs.
Among patients who newly started an ACE inhibitor, test scores
typically rose 1.2 points in the first six months -- which was as
long as that group was followed. The rest of the study patients
were tracked for about a year-and-a-half.
Those are small differences in test scores. But if they
persisted over years, that could add up to a significant difference
in dementia patients' rate of decline, said Dr. William Molloy, one
of the researchers on the study.
Clinical trials are needed to confirm whether certain ACE
inhibitors do, in fact, slow down dementia, according to Molloy, a
professor of gerontology and rehabilitation at University College
Cork in Ireland.
He said he does not think the benefit linked to ACE inhibitors
is explained by better blood pressure control. There is animal
research showing that ACE inhibitors that cross into the brain may
have a stronger effect on brain functioning than ACE inhibitors
that do not breach the blood-brain barrier.
One possibility, Molloy said, is that the drugs reduce
inflammation in the brain.
But another expert not involved in the study urged caution. "I
don't think these findings should be used in any clinical
decision-making," said Dr. Jacobo Mintzer, chair of the Alzheimer's
Foundation of America's medical advisory board.
"This study supports the general concept that controlling blood pressure and other cardiovascular risk factors could have an effect" on dementia progression, said Mintzer, of Roper St. Francis Healthcare in Charleston, S.C.
But he agreed with Devi that the specific medication you take
for high blood pressure should be the one -- or ones -- that best
rein in your numbers.
The study was funded by government and private grants; none of
the researchers reports any financial conflicts of interest.
The Alzheimer's Foundation of America has more on
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.